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ABSTRACT
Purpose: We attempted to improve the method of objective clinical evaluation of patients with 
benign prostatic enlargement and lower urinary tract symptoms. 
Materials and Methods: We compared the results of free uroflowmetry and transrectal ultra­
sound prostate size determination with those of pressure-flow analysis of bladder outlet obstruc­
tion in 871 consecutive elderly men. 
Results: Maximal flow, prostate size, and post-void residual and voided volumes were corre­
lated with bladder outlet obstruction to derive a clinical prostate score. 
Conclusions: Clinical prostate score shows a superior correlation with bladder outlet obstruc­
tion than isolated objective parameters or symptom scores.
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Urodynamics are the gold standard in the diagnosis of 
bladder outlet obstruction in patients with benign prostatic 
enlargement but the clinical value of uro dynamic investiga­
tion in daily practice has been criticized.1 In the past there 
has not been a great effort to improve the clinical method of 
diagnosis of bladder outlet obstruction in elderly men, prob­
ably because of the acceptable success rate of therapy (gen­
erally transurethral resection of the prostate). However, the 
number of alternative treatments currently available is rap­
idly increasing but they do not seem to have high success 
rates. On the other hand, the threshold for seeking medical 
care for lower urinary tract symptoms seems to have de­
creased, possibly because of the availability of these alterna­
tives. To take advantage of less invasive therapies selection 
criteria are needed. Improving clinical diagnosis may become 
useful for stratification of patients.
Urodynatnics remain invasive, time-consuming and costly, 
and will not be implemented in daily routine practice for 
establishing the diagnosis in every elderly man with lower 
urinary tract symptoms. The value of urodynamics in pre­
dicting the outcome of surgery is limited, This conclusion is 
based on reports that patients without uro dynamically con­
fined bladder outlet obstruction are symptomatically the 
same after transurethral resection of the prostate compared 
to those with obstruction when all patients underwent sur­
gery,2-4
However, we performed urodynamics routinely to assess 
all patients with benign pro static enlargement for more than 
2 years. The results of urodynamics were used to select 
patients who did not immediately require surgery for bladder 
outlet obstruction. In addition to complete urodynamics rec­
tal ultrasound of the prostate and at least 1 spontaneous free 
uroflowmetry were done in all patients. Serum prostate spe­
cific antigen was measured and prostate biopsies were ob­
tained when necessary. Furthermore, patients were asked to 
complete an International Prostate Symptom Score (I-PSS) 
and a Madsen symptom score questionnaire. We report the 
results of urodynamics in a large, referred but random group
Accepted for publication October 13, 1995.
of patients with benign pro static enlargement and lower 
urinary tract symptoms, The outcome of urodynamics was 
compared to the 2 symptom scores, and the free uroflowmetry 
results, post-void residual level and prostate size meas­
urement by transrectal ultrasound. Based on these compar­
isons a clinical score was developed, which may prove valu­
able to predict the probable presence of bladder outlet 
obstruction.
MATERIAL AND METHODS
We performed urodynamics in 871 consecutive men with 
benign prostatic enlargement and/or lower urinary tract 
symptoms in this retrospective study to analyze the grade of 
bladder outlet obstruction. Of the original 904 patients 33 
were excluded from study due to age younger than 50 years.5 
However, 16 of the excluded patients (46.9%, mean age 46.7 
years, range 41 to 49) had obstruction and the largest pros­
tate was 95 cm.3 (mean 30.2). All patients were referred to 
our clinic because of prostatism. In 23 patients (2.6%) not 
excluded from analysis the prostate was between 17 and 20 
cm.3. A few patients (1 to 2%) able to perform free urine flow 
were unable to void during urodynamics due to inhibition 
and were excluded from analysis.
All patients were considered neurologically normal based 
on history, symptoms and physical examination (no motor, 
sensory or reflex deficits). Urine sediment and culture were 
;ative at the time of urodynamics. Patients in acute reten­
tion were not included since retention is an almost absolute 
indication for surgery. However, patients with probably 
chronic large amounts of residual urine were included in the 
study when they were able to void during urodynamics.
A Dutch translation of the Madsen symptom score ques­
tionnaire was used, which has been available in The Neth­
erlands since its publication in English. It has been success­
fully used in many international multicenter studies. The 
International Consensus Committee of the World Health Or­
ganization (WHO) international consultation on benign pros­
tatic hyperplasia recommended translations of the I-PSS
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questionnaire.5 The Flemish/Dutch translation is similar to 
the Dutch translation, which we have used since publication 
of the original American Urological Association-7 symptom 
score questionnaire.
To evaluate the structure of the prostate and prostate 
volume transrectal ultrasound was performed using a Com- 
bison 330 scanner with a 7.5 MHz. transducer for transrectal 
scanning (Multiplane 3-D VRW 77AK). The planimetric 
method was used to calculate prostate volume. Free uroflow- 
metry was done privately when the patient presented with a 
normal to severe urge to void. Flow was measured using a 
Urodyn 1000* flowmeter,
Urodynamics were performed with an 8F transurethral 
lumen catheter with an intravesical micro-tip pressure sen­
sor. Before cystometry the bladder was emptied through the 
lumen of the transurethral catheter to quantify residual vol­
ume after free uroflowmetry. Abdominal pressure was re­
corded intrarectally with an 8F micro-tip sensor catheter. 
Pressure sensors were set at zero equals atmospheric pres­
sure before placement. The bladder was filled with water at 
20C at a filling speed of 50 ml. per minute with the patient 
supine. Filling was stopped when the patient expressed a 
strong urge to void, and voiding in the standing position was 
allowed privately.
Digitally stored urodynamic data were analyzed with a 
urodynamic analysis computer program developed at our 
department. To quantify bladder outlet obstruction pressure- 
flow graphs were fitted with a passive urethral resistance 
relation curve at the lowest pressure part of the graph. Min­
imal pressure during voiding and theoretical cross-sectional 
urethral lumen were derived using the passive urethral re­
sistance relation curve.6 Calculation of urethral resistance 
factor was based on the point of maximum flow (Qmax) and 
corresponding detrusor pressure.7 Correction for artifacts 
was done as necessary. Urethral resistance factor of 29 cm. 
water or greater indicated bladder outlet obstruction.8 The 
linear passive urethral resistance relation pressure-flow no­
mogram was used as a clinical classes scale: classes 0 and
1—no bladder outlet obstruction, 2 and 3—moderate obstruc­
tion and greater than 3—severe obstruction.
Statistical significance of the differences between mean 
values was tested with a paired samples t test when appro­
priate or a nonparametric Wilcoxon matched pairs signed 
ranks test as necessary. Differences between multiple group 
means were tested with Kruskal-Wallis 1-way analysis of 
variance. Pearson’s coefficient of correlation was used for 
correlation analysis. Logistic regression analysis was per­
formed to facilitate the development of a clinical score. A 
commercially available computer software package was used 
for statistical analysis.
RESULTS
Table 1 shows the average results of symptom scores, free
* Dantec Medical, Inc., Campbell, California.
Table 1, R esults  of investigations in 871 cases
Parameter Mean (SD)
Pt. age 64.6 (8.6)
Madsen symptom score 12.5 (4.5)
I-PSS 17.5 (7.0)
Free maximal flow (ml./sec.) 10.7 (4.9)
Free flow vol. (ml.) 258 (152)
Post-void residual (ml.) 76 (129)
Prostate size (cm.3) 44.7 (22.3)
Urodynamics:
Urodynamic capacity (ml.) 411 (138)
Maximal flow during urodynamics (ml./sec.) 7.31 (4.1)
Detrusor pressure at maximal flow (cm. water) 59.0 (29.5)
Urethral resistance factor 37.3 (19.5)
Minimal pressure during voiding (ml.) 30.6 (19.2)
Theoretical cross-sectional urethral lumen (mm.2) 3.5 (2.4)
uroflowmetry and ultrasound prostate volume determina­
tion. A self-administered I-PSS questionnaire was completed 
by 707 patients and a Madsen symptom score questionnaire 
was completed by 693. A free flow rate was recorded imme­
diately before urodynamics in 815 patients and evaluable 
residual urine data after this voiding were obtained for 807. 
All urine flow values were included when voided volume was 
greater than 50 ml. Data on prostate size were evaluable for 
813 patients.
The results of urodynamics for the group are also shown in 
table 1. Mean maximal flow during urodynamics (7.3 ml. per 
second) was significantly less than the mean free maximal 
flow (10.7 ml. per second, t test, p = 0.0001). The mean of the 
individual differences (free Qmax — urodynamic Qmax) was 
3.44 ml. per second (range of differences —33 to 20, standard 
deviation 4.63). In 62.6% of the cases the individual differ­
ence was less than 4 ml. per second. Eight patients with 
extreme differences (-33  to -7  ml. per second) due to unrep­
resentative voiding during urodynamics were excluded from 
further analysis at this point. Five patients with a much 
better flow during urodynamics (differences of greater than
14 ml. per second) were included in the study. Although 
linear passive urethral resistance relation estimation of blad­
der outlet obstruction was done in another 31 patients, ure­
thral resistance factor analysis was too unreliable for our 
study because the catheter slipped out during voiding or the 
uroflowmeter was disturbed. Therefore, these patients were 
excluded from urethral resistance factor analysis but in­
cluded in linear passive urethral resistance relation analysis. 
Complete urodynamic data on bladder outlet obstruction 
were available in 821 cases.
There was no selective exclusion because of artifacts al­
though patients who clearly had no obstruction tended to 
have larger differences in urodynamic flow rate, as we re­
ported earlier.10 Based on linear passive urethral resistance 
relation class 224 patients (28.2%) had no bladder outlet 
obstruction and based on urethral resistance factor analysis 
304 (38.5%) had no obstruction (table 2). Six patients had 
obstruction on urethral resistance factor analysis but not 
according to linear passive urethral resistance relation class, 
and 85 (9.9%) had moderate obstruction according to linear 
passive urethral resistance relation class and obstruction on 
urethral resistance factor analysis. Two patients had no ob­
struction on urethral resistance factor analysis and severe 
obstruction according to linear passive urethral resistance 
relation class. We observed a significant difference between 
free and urodynamic maximal flows. Although 119 patients 
(15.8%) had improved maximal flow during urodynamics, in 
632 (84.2%) maximal flow of pressure-flow voiding was less. 
We regard this difference (less than 4 ml. per second in 63% 
of cases) as systematic due to the transurethral catheter and 
the circumstances of the investigation. Since bladder outlet 
obstruction is quantified by the pressure-to-flow ratio, pas­
sive urethral resistance relation and linear passive urethral 
resistance relation analyses are not sensitive to maximal 
flow differences. Furthermore, pressure-flow analysis is cal­
ibrated for transurethral investigation.
Clinical parameters categorized according to urodynamic 
results are compared in tables 3 and 4. All parameters 
showed significant differences between the groups. However,
Table 2, Urodynamic classifications
Obstruction No. Pts. (%)
Linear passive urethral resistance
relation class:
0/1 None 224 (28.2)
2/3 Moderate 341 (39.5)
4/5/6 Severe 256 (32.2)
Urethral resistance factor None 304 (38.5)
Present 486 (61.5)
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Table 3. Presence or absence o f  b la d d er  outlet obstruction
according to urethral resistance factor
Mean (SD)
Obstruction 
(486 p ts j
No
Obstruction 
(304 pts.)
p Value
Pt. age 65.5 (8.4) 63.2 (8.8) 0.0005
Madsen symptom score 12.8 (4.4) 11.9 (4.3) 0.0196
I-PSS 17.8 (6.9) 16.6 (6.9) 0.0546
Free maximal flow (ml./sec.) 9,5 (3.8) 12.9 (5.3) 0.00001
Free flow vol. (ml.) 230 (136) 300 (165) 0.00001
Post-void residual (ml.) 78 (111) 50 (79) 0,00001
Prostate size (cm.3) 48.9 (24.3) 37.9 (15.0) 0.00001
T ab le  4. Presence or absence of b la d d er  outlet obsti'uction  
according to linear passive  urethral resistance relation
Mean (SD)
Severe Moderate No p Value 
Obstruction Obstruction Obstruction 
(256 pts.) (341 pts.) (224 pts.)
Pt, age
Madsen symptom score
I-PSS
Free maximal flow (ml/sec.) 
Free flow vol. (ml.)
Post-void residual (ml.) 
Prostate size (cm.3)
65.5 
13.2
18.6 
8.8
202
89
(8.6)
(4.2)
(6.9)
(3.6)
(116)
(115)
66.0
12.2
17.0
11.1 
272
61
(8.2)
(4.6) 
(6.9)
(4.7) 
(150)
(98)
63.3 (8.8) 
11.8 (4.2)
16.4 (6.9) 
12.6 (5.2)
299 (169)
50 (80) 
54.4 (27.3) 42.1 (17.8) 37.0 (15.0)
0.0003
0.0090
0.0074
0.00001
0.00001
0.00001
0,00001
the magnitude of the differences in symptoms between pa­
tients with and without bladder outlet obstruction was less 
than the differences on uroflowmetry or in prostate size. 
Analysis showed good correlation between both symptom 
scores and good correlation of the symptom scores with I-PSS 
quality of life (table 5).5 There was no difference in 
I-PSS quality of life score between patients with and without 
obstruction (mean score overall 3.83, with obstruction 3.87 
and without obstruction 3.75), Urodynamic correlations with 
clinical prostate score are shown in table 6. Figure 1 shows 
age and prostate size of all patients. There was a significant 
correlation of age with prostate size (r = 0.2946, p -  0.001). 
Table 7 shows average prostate size of distinct age groups in 
our study.
From the data in tables 3 and 4 we concluded that the 
existence of bladder outlet obstruction in these patients cor­
related with free uroflowmetry and prostate size at a high 
level compared to the number of symptoms. This conclusion 
does not imply that we consider measurement of symptoms 
or derivation of a reliable symptom score of lesser clinical 
importance. On the contrary, symptoms are the most fre­
quent reason for the patient to seek medical care, The level of 
symptoms and their bothersomeness for the patient are im­
portant indicators of the need for medical intervention and 
important means to evaluate the success of intervention. 
However, we found poor correlation between grade of bladder 
outlet obstruction and level of symptoms. Therefore, we con­
clude that the decision to treat can be based on symptoms 
and/or bothersomeness of symptoms but, especially if differ-
ent types of therapy are available, the treatm ent choice will 
be guided by the result of objective investigation(s). Since 
determination of prostate size and uroflowmetry with the 
quantification of post-void residual urine are simple meas­
urements with low morbidity, we found it worthwhile to 
derive a scoring system for these clinical investigations, 
which could be used to predict the presence of bladder outlet 
obstruction in an elderly m an with prostatic enlargement 
and lower urinary tract symptoms.
Development o f the clinical prostate score. Table 6 shows 
that of the parameters maximal flow is the most important 
predictor of bladder outlet obstruction because it correlates 
well with urodynamic parameters. The correlation coeffi­
cients of prostate size, voided volume and post-void residual 
follow respectively. Logistic regression analysis with these 4 
parameters versus obstruction or no obstruction confirmed 
that maximal flow was the best predictor for the presence of 
obstruction, The relative power or weight assigned to each 
parameter to predict bladder outlet obstruction was esti­
mated on the basis of this logistic regression. Therefore, 
logistic regression analysis was not an end point of analysis. 
The analysis was merely used as a tool to construct the 
clinical score. The 4 parameters entered in regression anal­
ysis showed only poor individual statistical correlation (best 
correlation maximal flow with voided volume, r2 = 0,478) 
and, therefore, logistic regression on these parameters was 
not confounded. The weight of the parameters derived from 
this analysis was used to assign points to the results of the 
various param eter values. The cutoff points of the classes 
were based on analysis of the histograms of the various 
parameters as well as on analysis of scatterplots of the pa­
rameters in relation to the quantifiers of bladder outlet ob­
struction.
Table 8 shows the parameters and the scoring points tha t 
we assigned to each parameter. Clinical prostate score, 
that is the total of the points achieved, was determined for 
770 patients and compared to the urodynamic diagnosis of 
bladder outlet obstruction in 705. The possible range was 0 to 
27 points and the average clinical prostate score was 10.4 
(standard deviation 5,8) in this group.
There was a significant difference in clinical prostate score 
of patients with and without bladder outlet obstruction 
(mean 7,3 points for the 271 patients without and mean of 
12.3 for the 434 with obstruction, t test, p <0.0001). In figure 
2 a urethral resistance factor of greater than 28 indicates 
obstruction. Referring to linear passive urethral resistance 
relation, mean values for no obstruction (7,5 points), moder­
ate obstruction (9.6) and severe obstruction (13,7) showed 
statistically significant differences (Kruskal-Wallis test, p 
<0.00001). Of the group 344 patients (48.8%) had a clinical 
prostate score of greater than 11 points of whom 247 (80,7%) 
had bladder outlet obstruction on urodynamics. Of the 250 
patients (35.5%) with a clinical prostate score of less than 8 
points 64% had no obstruction. Of the 55 patients with an 
I-PSS of 0 to 7 (mildly symptomatic) 26 (51%), of the 382 with 
an I-PSS of 8 to 19 (moderately symptomatic) 224 (61%) and 
of the 270 with an I-PSS of 20 or greater (severely symptom­
atic) 158 (63%) had obstruction.
T ab le  5. Correlations
Maximal 
Flow During 
Urodynamics
Detrusor Pressure 
at Maximal Flow
Urethral
Resistance
Factor“
I-PSS 
Quality of 
Life Scoref
Madsen
Symptom
Score
I-PSS
Pt. age 0.1506* 0.0663 0.1214 -0.0740 -0.0625
Total I-PSS -0.0651 0.1074* 0.1090 0.5067 0.7378t
Total Madsen symptom score —0.0930 0.0988 0.1204 0.4369
I-PSS quality of life score -*0.0430 0.0948 0.1043
Urethral resistance factor -0.5801t 0.8492t
Detrusor pressure at maximal flow -0,26401*
* One-tailed test with significance at —0.01. 
t One-tailed test with significance at —0.001,
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T able 6. Correlations
Detrusor Pressure 
at Maximal Flow*
Urethral
Resistance
Factor*
Minimal Pressure 
During Voiding
Theoretical 
Cross-Sectional 
Urethral Lumen*
Prostate size 0.2682 0.2894 0.2863* -0.2016
Free maximal flow -0.2475 -0.4208 -0.2122* 0.4581
Free flow vol. -0.1983 -0.2944 -0.1954* 0.2145
Post-void residual 0.1545 0.1937 0.1075t -0.1785
Clinical prostate score 0.3957 0.5272 0.3185* -0.4582
* One-tailed test with significance at -0.001.
t  One-tailed test with significance at -0.01.
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F ig . 2. Urethral resistance factor (URA) grade of obstruction and 
clinical prostate score (CLIPS).
Table 7. P atien t age a n d  prosta te  size
Age Greater Than No. Pts. Cm.3 Prostate Size (SD)
50 67 34.8 (13,4)
55 115 40.4 (17.8)
60 158 41.6 (20.4)
65 147 47.6(20.1)
70 116 50.6(26.6)
75 58 60.2(25.0)
80 21 48,0 (22.0)
85 3 56.6(09,9)
Table i8
No. Points
Prostate size (cm.3):
Less than 30 0
30-60 3
Greater than 60 6
Free maximal flow (ml./sec.):
Greater than 12 0
8-12 5
4—8 10
Less than 4 15
Post-void residual (ml.):
Less than 30 0
30-100 2
Greater than 100 4
Voided vol. (ml.):
Greater than 300 0
200-300 1
Less than 200 2
DISCUSSION
In a large group of men with benign pro static enlargement 
and symptoms of lower urinary tract dysfunction we confirm 
a poor correlation between urodynamic findings and symp­
toms.11-13 The correlation of the results of urodynamics with 
prostate size, as determined by transrectal ultrasound or free 
uroflowmetry, was better.14,15 The correlation of isolated ob­
jective parameters is generally believed to be too inaccurate 
for clinical decision making. However, we combined the re­
sults of these noninvasive investigations to derive a clinical 
scoring system, This score correlated well with the results of 
urodynamics. We excluded a limited number of patients from 
these analyses to prevent a retrospective observation bias, 
The procedures for prostate size estimation and uroflow- 
metry are routine, and results were not manipulated. Since 
the core of the diagnosis was urodynamics, some of these 
results have been excluded, as stated previously. Therefore, 
we have also included 1 urine flow value recorded just before 
urodynamics. Because there is a possibility that urine flow 
could improve on another occasion and almost 16% of the 
patients had better urine flow during urodynamics, we in­
cluded these data. Furthermore, since urine flow can only 
improve with more attempts (a worse result shall not be used 
for analysis) the positive predictive value of the score will 
also only improve. However, prospective use of the score is 
needed to evaluate the validity of the scoring points.
It is important to emphasize that this score will never 
perfectly predict the presence or confirm the absence of blad­
der outlet obstruction, The sensitivity of clinical prostate 
score to detect obstruction when the lower score limit is 11 
points is high in this group of patients (80.7%) but specificity 
is less (53.1%). Lowering the limit increases specificity, and 
only 11.8% of the patients with a clinical prostate score of less 
than 8 had severe bladder outlet obstruction on urodynamics.
The correlation between clinical prostate score and the 
results of urodynamics is superior to that between urody­
namic bladder outlet obstruction and symptoms or symptom 
scores. For example, of the patients with mild or moderate 
symptoms 57.2% had obstruction. Also, the combination of 
clinical parameters in clinical prostate score results in a 
superior correlation with urodynamic results compared to 
the results of the separate clinical parameters, as shown by 
the coefficients of correlation of these parameters with the 
available obstruction parameters (table 6).
I
t
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In general, clinical prostate score provides reassurance for 
clinicians since it refers to clinical experience. The older 
patient wiui a large prostate, small voided volume, low max­
imal flow and large post-void residual is the ideal candidate 
for the removal of obstruction. In our opinion this score and 
its good correlation with bladder outlet obstruction are math­
ematical evidence of this clinical experience. However, trea t­
ing patients can never depend on the calculation of a score, 
and clinical prostate score must be interpreted as an indica­
tion of the relative value of each parameter or investigation 
in establishing the likelihood of obstruction without perform­
ing complete invasive urodynamics.
Others have studied symptoms and prostate size in a 
screened population.16*17 Men were excluded from study 
when they had already been treated by a urologist 
and/or when they had a history of prostatic surgery. The 
prostates of the patients in our study were plus or minus 5 to
10 cm.3 larger on average compared to those of the group that 
was screened, indicating that the exclusion of treated pa­
tients in the screening study may have caused bias toward 
smaller prostate size. Mean I-PSS of the reported screening 
group was 6.2 points and 30% had moderate or severe symp­
toms. Mean I-PSS quality of life score was 1.4, and there was 
a high correlation between I-PSS and quality of life. The 
correlation between I-PSS and uroflowmetry parameters was 
low.16 The pattern of these correlations is comparable to our 
results, although prostate sizes, mean total I-PSS and both­
ersomeness (I-PSS quality of life score) were lower in the 
screening study. We conclude that our clinical patients dif­
fered significantly on average from the screened men only in 
the level of symptoms and less in objective parameters. The 
high correlation of I-PSS quality of life score and total I-PSS 
in both studies indicates that symptoms are predominantly 
influenced by bothersome ness and to a lesser extent by blad­
der outlet obstruction.18
WHO proposed recommendations concerning the diagnos­
tic evaluation of patients presenting with symptoms suggest­
ing prostatism. Uroflowmetry and measurement of residual 
urine are recommended diagnostic tests, while the assess­
ment of prostatic size and shape is regarded as optional.6 
However, alternative treatments are not included in the 
WHO decision tree and reference values are not provided. 
The outcome of surgical treatment in relation to diagnostic 
investigations has been the subject of other studies.4*19’20 
Flow rate has been shown to predict outcome. The outcome 
was less favorable in patients with a preoperative maximal 
flow of 15 ml. per second or greater. Uroflowmetry is recom­
mended for the evaluation of prostatism,21 and we confirm an 
acceptable correlation of uroflowmetry with bladder outlet 
obstruction. Combining the results of uroflowmetry with 
those of other diagnostic tests, as shown in our study, im­
proves diagnostic accuracy. We are convinced that the use of 
objective testing in referred patients with benign prostatic 
enlargement and lower urinary tract symptoms will augment 
the justification of treatment, and that clinical prostate score 
will be helpful in the selection of candidates for surgery or 
alternative therapies. Clinical prostate score can be used to 
select patients for surgical treatment when urodynamics are 
not available but it can also be used to select patients for 
urodynamics.
A recent study shows that patients with moderate bother­
someness of symptoms do better after transurethral resec­
tion of the prostate compared to watchful waiting.22 Although 
reoperation for stricture was performed in 9.3% of the pa­
tients within 3 years of foliowup and 8.2% of the transure­
thral resection of the prostate procedures were regarded as 
unsuccessful, patients in the watchful waiting group had 
more retention and more infections. An increasingly large 
amount of residual urine was regarded as an indication for 
crossover to surgery in 8.7% of the cases, while 30 to 40% of 
those in the watchful waiting group had symptomatic im-
provement. Hypothetically these men could represent the 
40% of patients without bladder outlet obstruction in our 
group w ith moderate symptoms. However, the symptomatic 
effect of watchful waiting in patients stratified according to 
urodynamic grade of bladder outlet obstruction is not yet 
established, although watchful waiting, when partially indi­
cated by the results of urodynamics, can be a serious alter­
native.23 The findings of Wasson et al22 may confirm our 
results th a t solitary assessment of symptoms is ineffective 
for selecting candidates for alternatives to surgery. There­
fore, we find it  confusing tha t O ester ling, in debating the 
alternatives to treatm ent, referred to the study of Wasson et 
ai and recommended selection of treatment based on symp­
toms, stating tha t there exist only relative indications to 
treat and that “the patient must be consulted.”24
c o n c l u s io n s
Prostate size and the results of free uroflowmetry meas­
urement provide useful nonurodynamic indicators for the 
presence of bladder outlet obstruction. We used a combina­
tion of these investigations to derive a urodynamically vali­
dated, noninvasive, disease specific clinical prostate score. In 
comparison with analysis of symptoms or separate analysis 
of clinical evaluations, this clinical prostate score better pre­
dicts the presence of bladder outlet obstruction.
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